122 related articles for article (PubMed ID: 32306138)
21. Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide.
Vilela RM; Lands LC; Meehan B; Kubow S
Int Immunopharmacol; 2006 Nov; 6(11):1651-64. PubMed ID: 16979119
[TBL] [Abstract][Full Text] [Related]
22. Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.
Caretti A; Vasso M; Bonezzi FT; Gallina A; Trinchera M; Rossi A; Adami R; Casas J; Falleni M; Tosi D; Bragonzi A; Ghidoni R; Gelfi C; Signorelli P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):775-790. PubMed ID: 28439630
[TBL] [Abstract][Full Text] [Related]
23. Fenretinide favorably affects mucins (MUC5AC/MUC5B) and fatty acid imbalance in a manner mimicking CFTR-induced correction.
Garić D; De Sanctis JB; Dumut DC; Shah J; Peña MJ; Youssef M; Petrof BJ; Kopriva F; Hanrahan JW; Hajduch M; Radzioch D
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158538. PubMed ID: 31678518
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death.
Becker KA; Tümmler B; Gulbins E; Grassmé H
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):368-74. PubMed ID: 21078296
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the inflammasome by ceramide in cystic fibrosis lungs.
Grassmé H; Carpinteiro A; Edwards MJ; Gulbins E; Becker KA
Cell Physiol Biochem; 2014; 34(1):45-55. PubMed ID: 24977480
[TBL] [Abstract][Full Text] [Related]
26. Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection.
Zhang Y; Li X; Grassmé H; Döring G; Gulbins E
J Immunol; 2010 May; 184(9):5104-11. PubMed ID: 20351190
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
[TBL] [Abstract][Full Text] [Related]
28. Ceramide mediates lung fibrosis in cystic fibrosis.
Ziobro R; Henry B; Edwards MJ; Lentsch AB; Gulbins E
Biochem Biophys Res Commun; 2013 May; 434(4):705-9. PubMed ID: 23523785
[TBL] [Abstract][Full Text] [Related]
29. Fatty acid metabolism in cystic fibrosis.
Strandvik B
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):121-9. PubMed ID: 20673710
[TBL] [Abstract][Full Text] [Related]
30. No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis.
Werner A; Bongers ME; Bijvelds MJ; de Jonge HR; Verkade HJ
J Lipid Res; 2004 Dec; 45(12):2277-86. PubMed ID: 15466369
[TBL] [Abstract][Full Text] [Related]
31. The "Goldilocks effect" in cystic fibrosis: identification of a lung phenotype in the cftr knockout and heterozygous mouse.
Cohen JC; Lundblad LK; Bates JH; Levitzky M; Larson JE
BMC Genet; 2004 Jul; 5():21. PubMed ID: 15279681
[TBL] [Abstract][Full Text] [Related]
32. Cystic Fibrosis: Pathophysiology of Lung Disease.
Bergeron C; Cantin AM
Semin Respir Crit Care Med; 2019 Dec; 40(6):715-726. PubMed ID: 31659725
[TBL] [Abstract][Full Text] [Related]
33. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis.
Becker KA; Grassmé H; Zhang Y; Gulbins E
Cell Physiol Biochem; 2010; 26(1):57-66. PubMed ID: 20502005
[TBL] [Abstract][Full Text] [Related]
34. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses.
Bodas M; Mazur S; Min T; Vij N
Respir Res; 2018 Jan; 19(1):2. PubMed ID: 29301535
[TBL] [Abstract][Full Text] [Related]
37. Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice.
van Heeckeren AM; Schluchter M; Xue L; Alvarez J; Freedman S; St George J; Davis PB
Infect Immun; 2004 Mar; 72(3):1479-86. PubMed ID: 14977953
[TBL] [Abstract][Full Text] [Related]
38. Lung arginase expression and activity is increased in cystic fibrosis mouse models.
Jaecklin T; Duerr J; Huang H; Rafii M; Bear CE; Ratjen F; Pencharz P; Kavanagh BP; Mall MA; Grasemann H
J Appl Physiol (1985); 2014 Aug; 117(3):284-8. PubMed ID: 24925982
[TBL] [Abstract][Full Text] [Related]
39. Ethanol administration to cystic fibrosis knockout mice results in increased fatty acid ethyl ester production.
Blanco PG; Salem RO; Ollero M; Zaman MM; Cluette-Brown JE; Freedman SD; Laposata M
Alcohol Clin Exp Res; 2005 Nov; 29(11):2039-45. PubMed ID: 16340462
[TBL] [Abstract][Full Text] [Related]
40. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.
Durie PR; Kent G; Phillips MJ; Ackerley CA
Am J Pathol; 2004 Apr; 164(4):1481-93. PubMed ID: 15039235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
